Tirzepatide
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, offering enhanced metabolic benefits.
Visit Trusted SourceMechanism of Action
Activates both GIP and GLP-1 receptors, providing synergistic effects on appetite suppression, glucose regulation, and fat metabolism.
Dosing Overview
Research protocols start at 2.5mg weekly, titrating up to 5-15mg weekly.
Timeline of Effects
Appetite suppression within days. Significant weight changes over 12-20 weeks.
Stack Suggestions
MOTS-C, Cagrilintide, Tesamorelin
Safety Notes
May cause GI effects during titration. Start low and increase gradually. For research purposes only.
Reconstitution Guide
Typically comes pre-mixed. If powder: follow manufacturer guidelines.
Ready to Research Tirzepatide?
Get premium quality peptides from our trusted supplier with exclusive community discounts.
Shop Optimum Formula